AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Radiomic features on contrast-enhanced images of the remnant liver predict the prognosis of hepatocellular carcinoma after partial hepatectomy

Meilong Wua,b,cLiping Liua,b,cXiaojuan Wangd,e,f,gYing Xiaof,hShizhong Yangd,e,f,g( )Jiahong Dongd,e,f,g( )
Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People’s Hospital, Shenzhen 518020, China
The Second Clinical Medical College, Jinan University, Shenzhen 518020, China
The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, China
Hepato-pancreato-biliary Center, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
Key Laboratory of Digital Intelligence Hepatology, Chinese Ministry of Education , Beijing 102218, China
School of Clinical Medicine, Tsinghua University, Beijing 100084, China
Research Unit of Precision Hepatobiliary Surgery Paradigm, Chinese Academy of Medical Sciences, Beijing 102218, China
Department of Pathology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
Show Author Information

Abstract

Background and aims

Radiomic features extracted from preoperative contrast-enhanced computed tomography (CT) images have been shown to predict the prognosis of hepatocellular carcinoma (HCC). However, the prognostic role of radiomic features obtained from postoperative contrast-enhanced CT images of the remnant liver remains unclear. This study explored the prognostic value of radiomic features extracted from postoperative contrast-enhanced CT images in patients with HCC.

Methods

Robust radiomic features were obtained from postoperative contrast-enhanced CT images for 78 patients with primary HCC and used to construct a radiomics score. A clinical model and a combined model that integrated clinicopathological indicators and the radiomics score were established. The predictive performance of the model was assessed using the concordance index and net reclassification index.

Results

The postoperative radiomics score for the remnant liver was an independent prognostic factor for disease-free survival (DFS) and overall survival (OS). The combined model was not inferior to the clinical model in predicting DFS but was superior in predicting OS. The net reclassification index confirmed that the combined model was more accurate and efficient in predicting OS and DFS. The radiomics score for DFS was significantly associated with tumor thrombus in the portal vein and the postoperative neutrophil-lymphocyte ratio. The radiomics score for OS was associated with multiple tumors, microvascular invasion, and tumor thrombus in the portal vein.

Conclusion

Postoperative contrast-enhanced CT radiomic features of the remnant liver were valuable prognostic indicators that could potentially reflect tumor burden and postoperative inflammatory status and provide more information for clinical decision-making.

References

[1]

Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018. https://doi.org/10.1038/nrdp.2016.18.

[2]

Giuliante F, Ardito F, Pinna AD, et al. Liver resection for hepatocellular carcinoma ≤3 Cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg 2012; 215(2):244–54. https://doi.org/10.1016/j.jamcollsurg.2012.04.013.

[3]

Tourkochristou E, Assimakopoulos SF, Thomopoulos K, et al. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Front Immunol 2022;13:965548. https://doi.org/10.3389/fimmu.2022.965548.

[4]

Wu M, Yang S, Feng X, et al. Combining preoperative and postoperative inflammatory indicators can better predict the recurrence of hepatocellular carcinoma after partial hepatectomy. J Inflamm Res 2021;14:3231–45. https://doi.org/10.2147/JIR.S316177.

[5]

Chen ZH, Zhang XP, Wang H, et al. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and metaanalysis. HPB 2019;21(8):935–44. https://doi.org/10.1016/j.hpb.2019.02.003.

[6]

Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 2019; 70(6):1133–44. https://doi.org/10.1016/j.jhep.2019.02.023.

[7]

Zhou LQ, Wang JY, Yu SY, et al. Artificial intelligence in medical imaging of the liver. World J Gastroenterol 2019;25(6):672–82. https://doi.org/10.3748/wjg.v25.i6.672.

[8]

Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017;14(12):749–62. https://doi.org/10.1038/nrclinonc.2017.141.

[9]

Liu Z, Wang S, Dong D, et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 2019;9(5): 1303–22. https://doi.org/10.7150/thno.30309.

[10]

Zhang J, Wang X, Zhang L, et al. Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types. Ann Transl Med 2020;8(13):820. https://doi.org/10.21037/atm-19-4668.

[11]

Liu Q, Li J, Liu F, et al. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Cancer Imaging 2020; 20(1):82. https://doi.org/10.1186/s40644-020-00360-9.

[12]

Jiang C, Cai YQ, Yang JJ, et al. Radiomics in the diagnosis and treatment of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2023;22(4):346–51. https://doi.org/10.1016/j.hbpd.2023.03.010.

[13]

Chen X, Tang Y, Wu D, et al. From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma. Front Oncol 2023;13:1278467. https://doi.org/10.3389/fonc.2023.1278467.

[14]

Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 2017;16:1. https://doi.org/10.4103/jcar.JCar_9_16.

[15]

Tahmasebi Birgani M, Carloni V. Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy. Int J Mol Sci 2017;18(2):405. https://doi.org/10.3390/ijms18020405.

[16]

Shen J, Dai J, Zhang Y, et al. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: a multicentre study. J Viral Hepat 2021;28(11):1587–96. https://doi.org/10.1111/jvh.13606.

[17]

Martins-Filho SN, Paiva C, Azevedo RS, et al. Histological grading of hepatocellular carcinoma-a systematic review of literature. Front Med 2017;4:193. https://doi.org/10.3389/fmed.2017.00193.

[18]

Ji GW, Zhu FP, Xu Q, et al. Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study. Radiology 2020;294(3):568–79. https://doi.org/10.1148/radiol.2020191470.

[19]

van Griethuysen Jjm, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77(21):e104–7. https://doi.org/10.1158/0008-5472.CAN-17-0339.

[20]

Bogowicz M, Riesterer O, Bundschuh RA, et al. Stability of radiomic features in CT perfusion maps. Phys Med Biol 2016;61(24):8736–49. https://doi.org/10.1088/1361-6560/61/24/8736.

[21]

Zheng BH, Liu LZ, Zhang ZZ, et al. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients. BMC Cancer 2018;18(1): 1148. https://doi.org/10.1186/s12885-018-5024-z.

[22]

Wright MN, Dankowski T, Ziegler A. Unbiased split variable selection for random survival forests using maximally selected rank statistics. Stat Med 2017;36(8): 1272–84. https://doi.org/10.1002/sim.7212.

[23]

Guiot J, Vaidyanathan A, Deprez L, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev 2022;42(1): 426–40. https://doi.org/10.1002/med.21846.

[24]

Han J, Li ZL, Xing H, et al. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB 2019;21(8):962–71. https://doi.org/10.1016/j.hpb.2018.11.005.

[25]

Wu M, Yang S, Feng X, et al. Prognostic value of the postoperative neutrophillymphocyte ratio in solid tumors: a meta-analysis. PLoS One 2021;16(4):e0250091. https://doi.org/10.1371/journal.pone.0250091.

[26]

Hanazaki K, Kajikawa S, Koide N, et al. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001;96(4):1243–50. https://doi.org/10.1016/S0002-9270(00)02427-8.

[27]

Morise Z. Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease. Transl Gastroenterol Hepatol 2018;3:41. https://doi.org/10.21037/tgh.2018.07.01.

[28]

Zhang X, Li C, Wen T, et al. Postoperative prognostic nutritional index predicts survival of patients with hepatocellular carcinoma within Milan criteria and hypersplenism. J Gastrointest Surg 2017;21(10):1626–34. https://doi.org/10.1007/s11605-017-3414-1.

[29]

Hai Y, Chen N, Wu W, et al. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy. BMC Cancer 2018;18(1):1011. https://doi.org/10.1186/s12885-018-4909-1.

[30]

Matsubara D, Arita T, Nakanishi M, et al. The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int J Clin Oncol 2020;25(4): 602–13. https://doi.org/10.1007/s10147-019-01580-1.

[31]

Huang G, Lai ECH, Lau WY, et al. Posthepatectomy HBV reactivation in hepatitis B–related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg 2013;257(3):490–505. https://doi.org/10.1097/sla.0b013e318262b218.

[32]

Cholankeril G, Kramer JR, Chu J, et al. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol 2023;78(3):493–500. https://doi.org/10.1016/j.jhep.2022.10.035.

[33]

Limkin EJ, Sun R, Dercle L, et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol 2017;28(6): 1191–206. https://doi.org/10.1093/annonc/mdx034.

[34]

Moris D, Shaw BI, McElroy L, et al. Using hepatocellular carcinoma tumor burden score to stratify prognosis after liver transplantation. Cancers (Basel) 2020;12(11): 3372. https://doi.org/10.3390/cancers12113372.

[35]

Haarburger C, Müller-Franzes G, Weninger L, et al. Radiomics feature reproducibility under inter-rater variability in segmentations of CT images. Sci Rep 2020;10(1):12688. https://doi.org/10.1038/s41598-020-69534-6.

[36]

Ibrahim A, Primakov S, Beuque M, et al. Radiomics for precision medicine: current challenges, future prospects, and the proposal of a new framework. Methods 2021; 188:20–9. https://doi.org/10.1016/j.ymeth.2020.05.022.

iLIVER
Cite this article:
Wu M, Liu L, Wang X, et al. Radiomic features on contrast-enhanced images of the remnant liver predict the prognosis of hepatocellular carcinoma after partial hepatectomy. iLIVER, 2024, 3(1). https://doi.org/10.1016/j.iliver.2024.100079

203

Views

0

Crossref

Altmetrics

Received: 29 October 2023
Revised: 02 December 2023
Accepted: 12 December 2023
Published: 06 February 2024
© 2024 The Author(s). Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return